Hyperglycemia in Acute COVID-19 is Characterized by Adipose Tissue Dysfunction and Insulin Resistance

COVID-19 has proven to be a metabolic disease resulting in adverse outcomes in individuals with diabetes or obesity. Patients infected with SARS-CoV-2 and hyperglycemia suffer from longer hospital stays, higher risk of developing acute respiratory distress syndrome (ARDS), and increased mortality co...

Descripción completa

Detalles Bibliográficos
Autores principales: Reiterer, Moritz, Rajan, Mangala, Gómez-Banoy, Nicolás, Lau, Jennifer D., Gomez-Escobar, Luis G., Gilani, Ankit, Alvarez-Mulett, Sergio, Sholle, Evan T., Chandar, Vasuretha, Bram, Yaron, Hoffman, Katherine, Rubio-Navarro, Alfonso, Uhl, Skyler, Shukla, Alpana P., Goyal, Parag, tenOever, Benjamin R., Alonso, Laura C., Schwartz, Robert E., Schenck, Edward J., Safford, Monika M., Lo, James C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010756/
https://www.ncbi.nlm.nih.gov/pubmed/33791724
http://dx.doi.org/10.1101/2021.03.21.21254072

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010756/
https://www.ncbi.nlm.nih.gov/pubmed/33791724
http://dx.doi.org/10.1101/2021.03.21.21254072

Ejemplares similares